Artificial Intelligence-Based Fluid Quantification in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated with Faricimab A real-life Study

被引：0
|
作者：
Stanzel, Boris V. [1 ]
Messias, Andre Marcio [1 ]
Lorenz, Anna Theresa [1 ]
Darwisch, Warda [1 ]
Haring, Florian [1 ]
Roberts, Philipp K. [1 ]
Julich-Haertel, Henrike [1 ,2 ]
Boden, Karl Thomas [1 ]
Szurman, Peter [1 ,2 ]
机构：
[1] Knappschafts Klinikum Saar GmbH, Krankenhaus Sulzbach, Eye Clin Sulzbach, Sulzbach, Saarland, Germany
[2] Klaus Heimann Eye Res Inst, Sulzbach, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2024年 / 65卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5642
引用
收藏
页数：3
相关论文
共 50 条
  • [41] ENVIRONMENTAL IMPACT OF AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA IN THE NETHERLANDS
    Quist, S.
    Paulissen, J.
    Freriks, R. D.
    VALUE IN HEALTH, 2023, 26 (12) : S317 - S318
  • [42] Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
    Garweg, Justus G. G.
    Blum, Claudine A. A.
    Copt, Rene-Pierre
    Eandi, Chiara M. M.
    Hatz, Katja
    Pruente, Christian F. F.
    Seelig, Eleonora
    Somfai, Gabor M.
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (02) : 639 - 655
  • [43] BUDGET IMPACT ANALYSIS OF FARICIMAB FOR TREATING PATIENTS WITH DIABETES MACULAR EDEMA OR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN COSTA RICA
    Hidalgo, J.
    Ordonez, J.
    Salas, M.
    Wu, L.
    Acevedo, R.
    Gutierrez, J. C.
    VALUE IN HEALTH, 2023, 26 (06) : S136 - S136
  • [44] Outcomes After Switching to Faricimab for Refractive Macular Edema in Treatment-Experienced Eyes with Neovascular Age-Related Macular Degeneration
    Qaseem, Yaqoob
    Hou, Kirk Kohwa
    Pettenkofer, Moritz S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3097 - 3102
  • [45] Comparative evaluation of generative artificial intelligence systems for patient queries on age-related macular degeneration and diabetic macular edema
    Napsugar Posa, Kincso
    Quezada Peralta, Gonzalo Elias
    Fabelo Hidalgo, Isabel
    Prat-Oriol, Bernat
    Abreu, Rodrigo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [46] Real-life experience of ranibizumab therapy for neovascular age-related macular degeneration from Turkey
    Cebeci, Zafer
    Yilmaz, Yusuf Cem
    Kir, Nur
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (02) : 267 - 273
  • [47] FARICIMAB VS. STANDARD OF CARE IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA: A COST-UTILITY ANALYSIS IN ITALY
    Ghetti, G.
    Porta, C.
    Fasci, A.
    VALUE IN HEALTH, 2023, 26 (12) : S192 - S192
  • [48] Real-life experience of ranibizumab therapy for neovascular age-related macular degeneration from Turkey
    Zafer Cebeci
    Yusuf Cem Yilmaz
    Nur Kir
    International Journal of Ophthalmology, 2018, (02) : 267 - 273
  • [49] Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
    Hoshino, Junki
    Matsumoto, Hidetaka
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 221 - 229
  • [50] Faricimab Combination Therapy for Sustained Efficacy in Neovascular Age-Related Macular Degeneration
    De La Huerta, Irina
    Kim, Stephen J.
    Sternberg, Paul, Jr.
    JAMA OPHTHALMOLOGY, 2020, 138 (09) : 972 - 973
12345